Pages that link to "Q34829498"

The following pages link to A CTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degeneration (Q34829498):

Displaying 27 items.

• RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer (Q26796202) (← links)
• Crystal structure of the globular domain of C1QTNF5: Implications for late-onset retinal macular degeneration (Q27671548) (← links)
• Characterisation of a C1qtnf5 Ser163Arg knock-in mouse model of late-onset retinal macular degeneration (Q28478012) (← links)
• C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes (Q28591360) (← links)
• Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15 (Q34260042) (← links)
• Endopeptidase cleavage generates a functionally distinct isoform of C1q/tumor necrosis factor-related protein-12 (CTRP12) with an altered oligomeric state and signaling specificity (Q34297181) (← links)
• Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration (Q34307274) (← links)
• Exome analysis identified a novel mutation in the RBP4 gene in a consanguineous pedigree with retinal dystrophy and developmental abnormalities (Q34494040) (← links)
• A degenerative retinal process in HIV-associated non-infectious retinopathy (Q34999270) (← links)
• Excess cones in the retinal degeneration rd7 mouse, caused by the loss of function of orphan nuclear receptor Nr2e3, originate from early-born photoreceptor precursors (Q35288269) (← links)
• 174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy. (Q35519187) (← links)
• Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects (Q35618559) (← links)
• Comparison of Mouse and Human Retinal Pigment Epithelium Gene Expression Profiles: Potential Implications for Age-Related Macular Degeneration (Q35827351) (← links)
• Loss of CTRP5 improves insulin action and hepatic steatosis (Q37070833) (← links)
• Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited macular degeneration (Q37380159) (← links)
• Metabolic function of the CTRP family of hormones. (Q37597694) (← links)
• LONGITUDINAL STRUCTURAL CHANGES IN LATE-ONSET RETINAL DEGENERATION. (Q39623585) (← links)
• Pathological Effects of Mutant C1QTNF5 (S163R) Expression in Murine Retinal Pigment Epithelium (Q40326076) (← links)
• Presence of rd8 mutation does not alter the ocular phenotype of late-onset retinal degeneration mouse model (Q41151515) (← links)
• A missense mutation in ASRGL1 is involved in causing autosomal recessive retinal degeneration. (Q46182724) (← links)
• A mutation in IFT43 causes non-syndromic recessive retinal degeneration. (Q46241142) (← links)
• Phenotypic findings in C1QTNF5 retinopathy (late-onset retinal degeneration). (Q54277138) (← links)
• Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective (Q90952568) (← links)
• Late-onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1 (Q92441788) (← links)
• The lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retina (Q92679506) (← links)
• Long-Term Effects of Gene Therapy in a Novel Mouse Model of Human MFRP-Associated Retinopathy (Q93382904) (← links)
• Dual SMAD inhibition and Wnt inhibition enable efficient and reproducible differentiations of induced pluripotent stem cells into retinal ganglion cells (Q97549363) (← links)